NAUT insider transaction filings
Nautilus Biotechnology, Inc. — 33 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-22. Screen NAUT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Epperly Melissa B, — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Akinsanya Karen — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Posard Matthew L. — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | McIlwain Matthew S — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | NAZEM FARZAD — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | AH Equity Partners Bio II, L.L.C. — 10% owner Andreessen Horowitz LSV Fund II, L.P. — 10% owner AH Bio Fund II, L.P. — 10% owner AH Equity Partners LSV II, L.L.C. — 10% owner Andreessen Marc L — 10% owner HOROWITZ BENJAMIN A — 10% owner | Sale (S): 4,615,974 @ $2.35 · Sale (S): 384,026 @ $2.35 | EDGAR |
| 2026-03-04 | 4 | Suzuki Kentaro — Chief Marketing Officer | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Murphy Matthew B. — General Counsel | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Mallick Parag — Chief Scientist, Director, 10% owner | Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Mowry Anna — CFO and Treasurer | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Sankar Subramanian — Senior VP, Product Development | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Weld Gwen E — Chief People Officer | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Patel Sujal M — CEO, President, and Secretary, Director, 10% owner | Purchase (P): 25,000 @ $2.61 | EDGAR |
| 2026-03-04 | 4 | Patel Sujal M — CEO, President, and Secretary, Director, 10% owner | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Suzuki Kentaro — Chief Marketing Officer | Purchase (P): 4,000 @ $1.49 | EDGAR |
| 2025-09-09 | 4 | Patel Sujal M — CEO, President, and Secretary, Director, 10% owner | Purchase (P): 116,500 @ $0.67 · Purchase (P): 83,500 @ $0.68 | EDGAR |
| 2025-09-05 | 4 | Murphy Matthew B. — General Counsel | Purchase (P): 20,000 @ $0.64 | EDGAR |
| 2025-06-25 | 4 | Epperly Melissa B, — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Akinsanya Karen — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Posard Matthew L. — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | McIlwain Matthew S — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | NAZEM FARZAD — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Mowry Anna — CFO and Treasurer | Purchase (P): 15,000 @ $0.77 | EDGAR |
| 2025-05-12 | 4 | Mallick Parag — Chief Scientist, Director, 10% owner | Purchase (P): 12,000 @ $0.73 · Purchase (P): 1,500 @ $0.73 | EDGAR |
| 2025-03-21 | 4 | Patel Sujal M — CEO, President, and Secretary, Director, 10% owner | Purchase (P): 53,300 @ $0.99 · Purchase (P): 23,933 @ $1.00 | EDGAR |
| 2025-03-04 | 4 | Murphy Matthew B. — General Counsel | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Mowry Anna — CFO and Treasurer | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Nelson Nicholas A. — CBO & Senior VP, Bus. Dev. | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Suzuki Kentaro — Chief Marketing Officer | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Mallick Parag — Chief Scientist, Director, 10% owner | Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Sankar Subramanian — Senior VP, Product Development | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Weld Gwen E — Chief People Officer | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Patel Sujal M — CEO, President, and Secretary, Director, 10% owner | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Nautilus Biotechnology, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-10-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NAUT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →